Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

Clinical trial NCT00267553 · TERMINATED

Trial details

NCT number: NCT00267553
Sponsor: Intarcia Therapeutics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms Neoplasms, Hormone-Dependent

Start date: 2005-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.